OperationsBoston
Sohail R. Zaidi
Chief Executive Officer
CFO at Intech Process Automation, COO at Ecopack Limited; began career at Imperial Chemical Industries.
Intech Process AutomationEcopack LimitedICI PLCHarvard Business School · INSEAD
Leadership · Board · Clinical collaborators
The people behind Nantheia™.
A senior team of pharmaceutical operators, clinicians and scientists — paired with a board chaired by accomplished company-builders and advised by three of the most-cited names in PTSD.
15 principals
Leadership
4 directors
Board
3 members
Scientific advisory
4 institutions
Clinical sites
2012
Founded
Leadership team
The principals.
Fifteen operators across the US and Jerusalem. Decades of pharmaceutical development experience paired with the inventors of the platform.
Filter by functionShowing · All (15)
OperationsBoston
Christopher Moore
SVP — Corporate & Regulatory Affairs
Career at Merck & Co. in senior international operations and management — including SVP Global Business.
Merck & Co.Banyu PharmaceuticalsPresident Emeritus, ANANDA
ScientificJerusalem
Nissim Garti, MS, PhD
Scientific R&D Partner · Inventor
Founder and Chairman of Lyotropic Delivery Systems Ltd; Professor of Chemistry and former Director of the Casali Institute at Hebrew University. Inventor of Liquid Structure™.
Hebrew University of JerusalemLyotropic Delivery SystemsFounder & Chairman, LDS Ltd.
ClinicalSalt Lake City
Jim Streisand, MD
Senior Medical Advisor
Board-certified anesthesiologist with 25+ years in clinical development, trial design and regulatory affairs.
GenzymeRevo BiologicsBS, MIT · MD, SUNY Buffalo
ScientificBoston
Bill McVicar, PhD
Senior Scientific Advisor
Pharmaceutical industry veteran with extensive experience leading start-ups through FDA approval.
NovartisRPR GencellSepracorInotekPhD Chemistry, U. Vermont
ClinicalBoston
Larry Blankstein, PhD
Clinical Operations
Extensive pharmaceutical industry experience in clinical research operations. Career at Genzyme.
GenzymeClinical operations consultancy
ClinicalBoston
Bonnie Goldmann, MD
Regulatory Advisor
Senior regulatory advisor with extensive experience preparing FDA submissions for novel therapeutics.
FDA regulatory consultancyPharma regulatory affairsSenior FDA submissions experience
ClinicalBoston
Katherine Kacena, PhD
Senior Statistician
Statistician with 15 years of research experience across industry, academia, and collaborations.
Johns HopkinsHarvard UniversityPhD, Johns Hopkins
R&DBoston
Steve Pondell
Quality & Regulatory Affairs
Senior pharmaceutical manufacturing executive with 20+ years across pharma, biologics and devices.
CMC consultancyPharma manufacturing20+ yrs pharma manufacturing
R&DJerusalem
Ariel Strahovsky
Chief Engineer
Chemical engineer with extensive experience establishing manufacturing processes in start-up companies.
Lyotropic Delivery SystemsChemical Engineering
R&DJerusalem
Michael Somuk
Documents & Control
Experienced in implementing new manufacturing processes and analytical methods as ANANDA develops its supply chain.
Pharma QC operationsMfg. & analytical methods
R&DJerusalem
Heidi Raben
Quality Assurance
Background as a pharmaceutical chemist and in pharmaceutical quality control; manages supply-chain quality.
Pharmaceutical QCPharmaceutical chemistry
FinanceBoston
Allan Kitterman
Controller
Experienced company financial manager and controller across a broad range of industries.
Multi-industry controllershipFinancial management
FinanceBoston
Nicole Reimers
Office Manager
Broad background managing day-to-day financial and office management processes at ANANDA.
Office & finance opsRecords & administration
R&DBoston
Sagren Thumbiran
Analytical Chemist
Experienced analytical chemist with broad pharmaceutical industry experience; manages ANANDA's analytical work.
Pharma analytical chemistryAnalytical chemistry
Board of Directors
Governance & strategic counsel.
Four directors covering science, regulatory, company-building and capital. Chaired by Mark J. Rosenfeld.
MJ
Chairman of the Board
Mark J. Rosenfeld, MS, PhD
US Scientist on the Joint UN FAO/IAEA Committee on Transboundary Diseases — innovated a device for medical use.
United Nations FAO/IAEAUniversity of UtahMedical policy
Lead Director
John Suh
Former CEO of LegalZoom — grew the company to >$6B in value. Earlier CEO of Studio Direct (Li & Fung).
CEO LegalZoomHarvard MBACastling Group
Director — Regulatory & Clinical
Susan Alpert, MD, PhD
Former Director of the USFDA Office of Device Evaluation and SVP of Global Regulatory Affairs at Medtronic.
Former FDA DirectorMedtronicC.R. Bard
RC
Director — Capital Markets
Roy Choi
Co-Founder and Managing Partner at Knighted, leading high-revenue enterprises in gaming, media and software.
KnightedPM StudiosColumbia / LBS
Scientific Advisory Board
Three of the most-cited names in PTSD.
Independent scientific advisors guiding clinical strategy for Nantheia™ across PTSD and adjacent neuropsychiatric indications.
John Krystal, MD
Yale University
Murray Stein, MD, MPH
UC San Diego
Barbara Rothbaum, PhD
Emory University
Clinical collaborations
Four institutions. One platform.
Investigator-led trials of Nantheia™ running at four leading US academic medical centers — covering PTSD, SAD, OUD, and smoking cessation.
NYU Grossman School of Medicine
New York, NYPrincipal investigator
Esther Blessing, MD, PhD (PI) · Charles Marmar, MD (Co-PI)
Study · drug
PTSD · Social Anxiety Disorder · Nantheia™
PTSD trial led by Esther Blessing (PI) with Charles Marmar as Co-PI — N=85, recruitment complete.
University of Nebraska Medical Center
Omaha, NEPrincipal investigator
Mathew Rizzo, MD, FAAN, FANA
Study · drug
PTSD — second program · Nantheia™
Second program in ANANDA's PTSD pipeline. Phase II trial enrolling at UNMC (N=140). Final readout Q1 2027.
Geffen School of Medicine, UCLA
Los Angeles, CAPrincipal investigator
Edythe London, PhD · Richard De La Garza, PhD
Study · drug
Opioid Use Disorder · Smoking Cessation · Nantheia™
UCLA Phase II in OUD — enrollment complete; final readout pending. UCLA Phase IIa Smoking Cessation enrolling.
Yale University School of Medicine
New Haven, CTPrincipal investigator
Joao P. De Aquino, MD
Study · drug
Opioid Use Disorder + chronic pain — Phase IIa · Nantheia™
Phase IIa investigator-initiated trial of Nantheia™ in OUD comorbid with chronic pain — currently enrolling.
Mission · Ananda Scientific · 2026
Grounded in science, driven by innovation, we strive to make a meaningful impact on global healthcare.